| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | NuvaRing | FAERS: 10 | US FAERS | |
| 2 | Norgestrel | FAERS: 7 | US FAERS | |
| 3 | Methylergonovine | FAERS: 6 | OFFSIDES US FAERS | |
| 4 | Desogestrel | FAERS: 5 | US FAERS | |
| 5 | etonogestrel | FAERS: 4 | US FAERS | |
| 6 | Citalopram | FAERS: 3 | US FAERS | |
| 7 | Dinoprostone | FAERS: 3 | US FAERS | |
| 8 | Fingolimod Hydrochloride | FAERS: 3 | US FAERS | |
| 9 | Venlafaxine Hydrochloride | FAERS: 3 | US FAERS | |
| 10 | Cabergoline | FAERS: 2 | OFFSIDES US FAERS | |
| 11 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 12 | Duloxetine Hydrochloride | FAERS: 2 | US FAERS | |
| 13 | Fentanyl | FAERS: 2 | US FAERS | |
| 14 | Isotretinoin | FAERS: 2 | US FAERS | |
| 15 | Oxcarbazepine | FAERS: 2 | US FAERS | |
| 16 | Oxytocin | FAERS: 2 | US FAERS | |
| 17 | Paroxetine | FAERS: 2 | US FAERS | |
| 18 | betamethasone acetate phosphate | FAERS: 2 | US FAERS | |
| 19 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 1 | US FAERS | |
| 20 | Dasatinib | FAERS: 1 | US FAERS | |
| 21 | Lamotrigine | FAERS: 1 | US FAERS | |
| 22 | Levobupivacaine | FAERS: 1 | US FAERS | |
| 23 | Lurasidone Hydrochloride | FAERS: 1 | US FAERS | |
| 24 | Misoprostol | FAERS: 1 | OFFSIDES US FAERS | |
| 25 | Nitrofurantoin | FAERS: 1 | US FAERS | |
| 26 | Ranitidine | FAERS: 1 | US FAERS | |
| 27 | apremilast | FAERS: 1 | US FAERS | |
| 28 | pimecrolimus | FAERS: 1 | US FAERS | |
| 29 | tazarotene | FAERS: 1 | OFFSIDES US FAERS | |
| 30 | Ascorbic Acid | OFFSIDES | ||
| 31 | Bupropion | OFFSIDES | ||
| 32 | Calcium Compounds | OFFSIDES | ||
| 33 | Terbutaline | OFFSIDES | ||
| 34 | Zidovudine | OFFSIDES | ||
| 35 | lamivudine, zidovudine drug combination | OFFSIDES | ||
| 36 | rizatriptan | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.